NEW YORK, July 3, 2018 /PRNewswire/ — News Commentary  

According to a research report provided by Marijuana Business Daily, cannabis retail sales growth-rates remain strong year-over-year as new markets emerge and more States legalize medical and recreational cannabis. Sales in 2018 are expected to increase by roughly 50% compared to last year, meaning sales value is on track to reach USD 8 Billion – USD 10 Billion by December of this year. The research also estimates that by 2022, annual retail cannabis sales in the United States could top USD 20 Billion, a 200% increase from 2017. As for the economic impact that the new and growing industry is expected to have, the data projects an estimated USD 28 Billion – USD 34 Billion in economic impact in 2018. Tidal Royalty Corp. (CSE:RLTY), Kush Bottles, Inc. (OTC:KSHB), Vitality Biopharma, Inc. (OTC:VBIO), Auxly Cannabis Group Inc. (OTC:CBWTF), mCig, Inc. (OTC:MCIG)

The recent progress, from both the political and technological grounds, has helped push the market in new directions. Editor-in-Chief at Arcview Market Research and Principal Analyst at BDS Analytics, Tom Adams, explained: “Our data shows positive indicators across the board for the legal cannabis industry, in North America and around the globe. The passage of the 2016 ballot initiatives and continued maturation of the existing Adult-Use markets are the primary drivers of the growth this year. That’s nothing compared to what we can expect in 2018 and beyond from Nevada’s tourism, and California and Canada planning to launch Adult-Use sales in 2018.”

Tidal Royalty Corp. (CSE:RLTY) just announced breaking news on Tuesday morning that, “The final terms of the Letter of Intent (“LOI”) entered into on April 30, 2018 with an established Oregon licensed operator (“Oregon Cannabis Company”) to finance the company’s expansion into the Massachusetts market. The Oregon Cannabis Company is a

Read More Here...